Key Documents
Charles DeBattista
- Professor - Med Center Line, Psychiatry & Behavioral Science - Psychopharmacology
Contact Information
- Clinical Offices
Psychiatry Department 401 Quarry Rd MC 5723 Stanford, CA 94305-5723 Telephone Work (650) 723-8335 Fax (650) 724-9900
Clinical Focus
- Psychiatry
Honors and Awards
- America's Best Doctors; Psychiatry, Best Doctors (2009-2010)
- Review Article of the Year, Primary Psychiatry (2004)
- Teacher of the Year, Dept. Of Psychiatry (1998, 2000, 2001)
Professional Education
- Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1995)
- Stanford University Medical Center (1993) CA
- Stanford University Medical Center (1993) CA
- Stanford University Medical Center (1990) CA
- UCSF School of Medicine (1989) CA
- DMH, UCSF/UC Berkeley Mental Health (1986)
- MD, UCSF Medicine (1989)
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: BMS, Lilly, Wyeth
- Equity: Corcept
Research Interests
Treatment resistant depression.
Novel biological interventions in the treatment of mental illness.
Anti-glucocorticoid drugs in the treatment of mood disorders.
Augmentation strategies in the treatment of depression.
Clinical Trials
- A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams to 100 Milligrams Daily in Women with Hypoactive Sexual Desire Disorder Recruiting
- rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure No longer recruiting
- A safety and efficacy trial of flibanserin in premenopausal women with HSDD No longer recruiting
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression Completed
Publications
- CNS Drugs. 2009; (5): 369-77
- Psychoneuroendocrinology. 2009; (7): 1012-8
- Contemp Clin Trials. 2009; (4): 284-8
- JAMA. 2008; (4): 395-404
- Ann Clin Psychiatry. 2007 Jul-Sep; (3): 153-9
- Biol Psychiatry. 2006; (5): 472-8
- Biol Psychiatry. 2006; (12): 1343-9
- Trends Endocrinol Metab. 2006; (3): 117-21
- CNS Spectr. 2006; (2): 93-102
- Behav Brain Res. 2006; (2): 225-9
- J Psychopharmacol. 2006; (3 Suppl): 11-8
- J Psychiatr Res. 2006; (1): 22-9
- Curr Psychiatry Rep. 2005; (6): 435-40
- J Clin Psychopharmacol. 2005; (5): 476-9
- Expert Rev Neurother. 2005; (1): 79-83
- J Clin Psychiatry. 2005; (7): 844-8
- Curr Alzheimer Res. 2005; (2): 125-9
- J Clin Psychiatry. 2005; (1): 85-93
- Psychoneuroendocrinology. 2004; (9): 1198-204
- J Clin Psychopharmacol. 2004; (1): 87-90
- Acta Anaesthesiol Scand. 2003; (1): 101-3
- J Clin Psychopharmacol. 2003; (1): 27-30
- J Clin Anesth. 2003; (1): 29-32
- Expert Opin Drug Saf. 2003; (4): 367-83
- Acta Anaesthesiol Scand. 2003; (9): 1064-6
- J Clin Psychiatry. 2003; (9): 1057-64
- J Mol Neurosci. 2002 Aug-Oct; (1-2): 201-6
- Biol Psychiatry. 2002; (5): 386-92
- J Affect Disord. 2001; (1): 27-36
- J ECT. 2001; (2): 91-8
- Ann Intern Med. 2001; (1): 47-60
- Am J Psychiatry. 2001; (12): 2083-5
- Am J Psychiatry. 2000; (7): 1095-100
- J Clin Psychopharmacol. 2000; (2): 274-5
- Am J Psychiatry. 2000; (8): 1334-7
- Arch Gen Psychiatry. 2000; (8): 755-60
- J Clin Psychiatry. 1999; 17-20
- J ECT. 1999; (2): 168-70
- J Clin Psychiatry. 1999; (3): 142-56
- Psychopharmacol Bull. 1998; (3): 355-9
- Biol Psychiatry. 1998; (5): 341-7
- J ECT. 1998; (4): 275-9
- Am J Psychiatry. 1997; (11): 1625-6
- Am J Psychiatry. 1996; (4): 577-8
- Am J Psychiatry. 1995; (8): 1235-4
- Headache. 1995; (8): 502-3